Cellectis (CLLS) Cash from Investing Activities (2015 - 2026)

Cellectis' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$6.2 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 245.99% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$39.9 million (up 58.7% YoY), while the FY2025 annual figure was -$29.5 million, up 71.32% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$6.2 million, down from $22.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $22.5 million in Q4 2025, with the low at -$106.4 million in Q2 2024.
• The 5-year median for Cash from Investing Activities is -$1.1 million (2022), against an average of -$9.2 million.
• Peak annual rise in Cash from Investing Activities reached 7544.33% in 2024, while the deepest fall reached 5916.34% in 2024.
• Cellectis' Cash from Investing Activities stood at -$730000.0 in 2022, then sank by 1770.27% to -$13.7 million in 2023, then retreated by 22.03% to -$16.7 million in 2024, then surged by 234.75% to $22.5 million in 2025, then tumbled by 127.46% to -$6.2 million in 2026.
• Business Quant data shows CLLS's Cash from Investing Activities at -$6.2 million in Q1 2026, $22.5 million in Q4 2025, and -$3.4 million in Q3 2025.